Mirxes(2629.HK)斩获首个政府采购订单,胃癌无创早筛技术落地民生领域

美港探案
Mar 05

本文为美港探案(MGresearch)原创作者:探长编辑:舟木据中国政府采购网公示,九江觅因生物科技有限公司成功中标2026年九江市濂溪区胃癌筛查与早期干预项目,中标金额人民币750万元。根据公司于3月5日盘后的公告,这是Mirxes成立以来的第一个公共卫生癌症早筛项目,也是其在中国的第一个政府采购项目,标志着其miRNA液体活检技术正式进入公共卫生体系,为胃癌早筛的规模化落地奠定关键基础。项目...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10